SCHEMBL6000757

SCHEMBL6000757

CCCC(CCC)c1ccc(N(Cc2ccc(-c3csc(CN(CC(=O)O)Cc4nc5ccccc5[nH]4)n3)cc2)C(C)C)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 1/20 0.50
PTPN1 P18031 1/20 0.50
TDP1 Q9NUW8 1/20 0.39
ROCK1 Q13464 1/20 0.34
SLC40A1 Q9NP59 2/20 0.33
MMP1 P03956 2/20 0.33
MMP13 P45452 2/20 0.33
BCHE P06276 1/20 0.32
ALDH1A1 P00352 4/20 0.32
PRKCZ Q05513 2/20 0.32
KMT2A Q03164 3/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
HTT P42858 1/20 0.32
MMP2 P08253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001153 0.94 PTPN1 (0.43) PTPN2PTPN1TDP1ROCK1SLC40A1
SCHEMBL6001118 0.88 PTPN2 (0.40) PTPN2PTPN1TDP1SLC40A1ALDH1A1
SCHEMBL6000201 0.86 PTPN1 (0.67) PTPN2PTPN1TDP1MMP1MMP13
SCHEMBL6000022 0.85 TDP1 (0.40) PTPN2PTPN1TDP1BCHEALDH1A1
SCHEMBL6000618 0.83 PTPN1 (0.51) PTPN2PTPN1ROCK1MMP1MMP13
SCHEMBL6000635 0.83 PTPN1 (0.49) PTPN2PTPN1ROCK1MMP1MMP13
SCHEMBL6001050 0.82 PTPN1 (0.55) PTPN2PTPN1MMP1MMP13ALDH1A1
SCHEMBL6000945 0.82 TDP1 (0.41) PTPN1TDP1SLC40A1BCHEALDH1A1
Hydrochloric Acid SCHEMBL5999167 0.82 PTPN1 (0.54) PTPN2PTPN1TDP1MMP1MMP13
Hydrochloric Acid SCHEMBL6000203 0.81 PTPN1 (0.54) PTPN2PTPN1MMP1MMP13MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US claimed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP claimed
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-06-08 US disclosed
EP-1553091-A1 HETEROAROMATIC PENTACYCLIC COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2005-07-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122181-A1 Heteroaromatic pentacyclic compound and medicinal use thereof PTPN11, PTPN1, PTPN3 PTPN2 11/4885PTPN1 2/4885TDP1 2972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.